RhumbLine Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $493K | Buy |
|
|||||
|
2025
Q2 | $441K | Buy |
|
|||||
|
2025
Q1 | $533K | Buy |
|
|||||
|
2024
Q4 | $756K | Sell |
|
|||||
|
2024
Q3 | $671K | Buy |
|
|||||
|
2024
Q2 | $715K | Buy |
|
|||||
|
2024
Q1 | $869K | Buy |
|
|||||
|
2023
Q4 | $916K | Buy |
|
|||||
|
2023
Q3 | $201K | Buy |
|
|||||
|
2023
Q2 | $265K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $306K | Buy |
|
|||||
|
2021
Q4 | $441K | Buy |
|
|||||
|
2021
Q3 | $522K | Buy |
|
|||||
|
2021
Q2 | $415K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $43K | Buy |
|
|||||
|
2016
Q4 | $167K | Buy |
|
|||||
|
2016
Q3 | $137K | Buy |
|
|||||
|
2016
Q2 | $92K | Buy |
|